CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 5 enrolled
Drug / intervention
[C-11]PBR28drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00547976
NCT00547976Phase 1Completed
CompareCT.gov

PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Carotid Atherosclerosis

National Institute of Mental Health (NIMH)·interventional·Posted Oct 23, 2007·Updated Apr 27, 2012

In Brief

A Phase 1 clinical trial evaluating [C-11]PBR28 for Atherosclerosis and Healthy. Completed, enrolled 5 participants across 2 sites.

Detailed Summary

Inflammation in the vascular wall is important in atherosclerosis and the blockage of the artery. The peripheral benzodiazepine receptor is involved in inflammation and in this protocol we will attempt to take pictures, using PET camera, of inflammation in patients with atherosclerosis and compare those of healthy people.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtherosclerosis, Healthy
CountriesUnited States
Collaborators--

Timeline

Phase 1CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 23, 2007
Enrollment StartOct 1, 2007
Primary CompletionAug 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 18.7 years ago

Interventions

[C-11]PBR28drug